Oxoplatin-Based Pt(IV) Lipoate Complexes and Their Biological Activity

Chem Biodivers. 2022 Oct;19(10):e202200695. doi: 10.1002/cbdv.202200695. Epub 2022 Sep 20.

Abstract

α-Lipoic acid, known for its anti-inflammatory and antioxidant activity, represents a promising ligand for Pt(IV) prodrugs. Three new Pt(IV) lipoate complexes were synthesized and characterized by NMR spectroscopy (1 H, 13 C, 195 Pt), mass spectrometry and elemental analysis. Due to the low solubility of the complex containing two axial lipoate ligands, further experiments to examine the biological activity were performed with two Pt(IV) complexes containing just one axial lipoate ligand. Both complexes exhibit anticancer activity and produce reactive oxygen species (ROS) in the cell lines tested. Especially, the monosubstituted complex can be reduced by ascorbic acid and forms adducts with 9-methylguanine (9MeG), which is favorable for the formation of DNA-crosslinks in the cells.

Keywords: Pt(IV) prodrugs; ROS; cyclovoltammetry; lipoic acid; multi-action.

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Antioxidants
  • Ascorbic Acid
  • Cell Line, Tumor
  • DNA
  • Ligands
  • Molecular Structure
  • Prodrugs* / chemistry
  • Prodrugs* / pharmacology
  • Reactive Oxygen Species / metabolism
  • Thioctic Acid*

Substances

  • Antineoplastic Agents
  • Antioxidants
  • Ascorbic Acid
  • diamminedichlorodihydroxyplatinum IV
  • DNA
  • Ligands
  • Prodrugs
  • Reactive Oxygen Species
  • Thioctic Acid
  • 9-methylguanine